Literature DB >> 18683191

Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.

Masaya Suzuki1, Shinji Kageyama, Kazuya Shinmura, Koji Okudela, Tomoyasu Bunai, Kiyoko Nagura, Hisaki Igarashi, Shinichiro Kiyose, Hiroki Mori, Hong Tao, Masanori Goto, Kazuya Takamochi, Takahiro Mochizuki, Kazuya Suzuki, Riuko Ohashi, Hiroshi Ogawa, Takeshi Yamada, Hiroshi Niwa, Toshihiro Tsuneyoshi, Haruhiko Sugimura.   

Abstract

BACKGROUND AND OBJECTIVES: There is a CA dinucleotide repeat polymorphism in the first intron of the epidermal growth factor receptor (EGFR) gene. Our aim was to examine the relationship between the CA repeat length in lung carcinoma and EGFR mutation, EGFR gene copy number, and EGFR protein expression level in the carcinoma.
METHODS: We examined 168 lung carcinomas for the length of the CA repeat polymorphism by PCR-polyacrylamide gel electrophoresis analysis, for EGFR mutations by sequencing analysis, for EGFR gene copy number by fluorescence in situ hybridization analysis, and for EGFR protein expression by immunohistochemical analysis.
RESULTS: When the carcinomas were divided into two groups according to the length of their CA repeat polymorphism, the EGFR protein expression level was found to be significantly higher in the shorter allele group than in the longer allele group (P = 0.0116), but its length was not associated with EGFR somatic mutations, high EGFR gene copy numbers, or clinicopathological factors, such as histological type or stage.
CONCLUSIONS: The results suggested that the length of the EGFR CA repeat polymorphism in lung carcinoma is inversely related with level of EGFR protein expression in the carcinoma. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683191     DOI: 10.1002/jso.21130

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

Review 1.  EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy.

Authors:  Christian Freudlsperger; Jeffrey R Burnett; Jay A Friedman; Vishnu R Kannabiran; Zhong Chen; Carter Van Waes
Journal:  Expert Opin Ther Targets       Date:  2010-11-26       Impact factor: 6.902

2.  Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China.

Authors:  Jun-Ling Wang; Yu-Dong Fu; Chao Zhang; Hong-Wei Li; Yan-Hong Gao; Xiu-Ping Li; Qian Xiong; Rui Li; Bo Hou; Ruo-Shan Huang; Jun-Feng Wang; Jian-Kun Zhang; Jia-Ling Lv
Journal:  Genes Environ       Date:  2022-05-23

3.  Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR.

Authors:  Zafer Cetin; Gulay Ozbilim; Abdullah Erdogan; Guven Luleci; Sibel Berker Karauzum
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

4.  EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.

Authors:  Yogesh K Vashist; Florian Trump; Florian Gebauer; Asad Kutup; Cenap Güngör; Viacheslav Kalinin; Rather Muddasar; Eik Vettorazzi; Emre F Yekebas; Burkhard Brandt; Klaus Pantel; Jakob R Izbicki
Journal:  Target Oncol       Date:  2013-02-02       Impact factor: 4.493

5.  Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients.

Authors:  Masayuki Shitara; Hidefumi Sasaki; Keisuke Yokota; Katsuhiro Okuda; Yu Hikosaka; Satoru Moriyama; Motoki Yano; Tomoya Kawaguchi; Akihito Kubo; Minoru Takada; Naoto Kitahara; Meinoshin Okumura; Akihide Matsumura; Keiji Iuchi; Yoshitaka Fujii
Journal:  Exp Ther Med       Date:  2012-08-23       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.